Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone Prophylaxis for Oxaliplatin-induced Hypersensitivity Reactions (Retrospective Study)
jRCT1030240152Completed
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hydrocortisone in gastrointestinal cancer (2 arms), sponsored by none. Primary endpoint: Allergy incidence. Started Jun 2024; status: completed.
02
Drugs
hydrocortisone
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on jRCT1030240152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030240152.